VS
Vijendra Singh Hada
About Vijendra Singh Hada
Data last updated:
Vijendra Singh Hada is a Director at Chemixal Pharmaceuticals Private Limited (since 2018) and Director at Lifecura Health Services Private Limited (since 2025). The companies operate in Business Services. The largest current company by reported revenue is Chemixal Pharmaceuticals Private Limited at ₹2.8 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chemixal Pharmaceuticals Private Limited U74999RJ2018PTC061020 | Director | 24 Apr 2018 | 2018 | ₹2.8 Lakh (FY 2020) | Active |
| Lifecura Health Services Private Limited U86100RJ2025PTC102286 | Director | 28 Apr 2025 | 2025 | Active |
Board colleagues of Vijendra Singh Hada
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravi Meena Shanker | 08109506 | Chemixal Pharmaceuticals Private Limited | Director |
| Mohammad Javed Khan | 11079795 | Lifecura Health Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijendra Singh Hada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijendra Singh Hada
Vijendra Singh Hada currently holds 2 directorships: Chemixal Pharmaceuticals Private Limited (Director, since 24 Apr 2018, revenue ₹2.8 Lakh (FY 2020)); Lifecura Health Services Private Limited (Director, since 28 Apr 2025).
Vijendra Singh Hada was first appointed on 24 Apr 2018 as Director at Chemixal Pharmaceuticals Private Limited. The most recent appointment on record is 28 Apr 2025 at Lifecura Health Services Private Limited.
The current boards of Vijendra Singh Hada's companies include Ravi Meena Shanker (Chemixal Pharmaceuticals Private Limited), Mohammad Javed Khan (Lifecura Health Services Private Limited).